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Calls for evidence-based policy often fail to recognise the fundamentally political nature of policy 
making. Policy makers must identify, evaluate and utilise evidence to solve policy problems in the 
face of competing priorities and political agendas. Evidence should inform but cannot determine 
policy choices. This paper draws on theories of ‘good governance’ to develop a framework for 
analysing and evaluating processes of evidence-informed policy making. ‘Good governance’ 
requires the use of appropriate bodies of high-quality evidence to inform policy and promotes 
decision-making processes that are transparent, accountable and open to contestation by the 
populations they govern.
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Introduction
Evidence-based policy making (EBPM) remains an ideal for which many actors in the 
field of health policy strive. Motivated by a commitment to alleviate human suffering, 
some have expressed frustration at the inability of policy makers to respond to advances 
in scientific knowledge which they claim point to effective policy interventions (cf 
Lee, 2003; Garner et al, 1998; Thamlikitkul, 2006; Feldman et al, 2001). Framing the 
issue in these terms, critics identify two main barriers to evidence-based policy. Either 
research evidence does not find its way into the hands of decision makers in forms 
which are accessible to them, or this evidence is ignored for political or ideological 
reasons. Politics is thus viewed as an impediment to effective policy, which must be 
overcome. 
Within this paradigm, the solutions offered to overcome the barriers to evidence use 
are more effective knowledge transfer, exchange or translation (from here on referred 
to collectively as knowledge translation) (cf Shaxson et al, 2012), and advocacy of 
EBPM as a political objective. This approach is manifested in a number of international 
initiatives which aim to improve the understanding, uptake, and utilisation of evidence 
debate
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for health policy, including the World Health Organization (WHO)’s Evidence 
Informed Policy Network (EVIPNet), the University of California, San Francisco 
(UCSF)’s Evidence to Policy Initiative (E2Pi), the Harvard School of Public Health’s 
Division of Policy Translation and Leadership Development, and the European 
Commission backed SUPPORT Programme (SUPPORT Programme, undated).
In some contexts, efforts to address a lack of capacity in both evidence synthesis 
and use are important steps in improved policy outcomes. However, it has been 
noted that the predominant discourse of EBPM fails to take sufficient account of the 
inherently political nature of the policy-making process (Sanderson, 2009; Russell 
et al, 2008; Pawson, 2006; Barnes and Parkhurst, 2014; Morgan-Trimmer, 2014; 
Greenhalgh and Wieringa, 2011; Smith, 2013a). Advocates of EBPM appear to assume 
that the right policy prescription can be derived from relevant research evidence. 
Non-implementation of a policy measure indicated by a particular evidence base is 
seen as a failure of the policy-making process to recognise or act on that evidence. 
The cause of these perceived failures is seen in many cases to be ‘politics’. In this 
context, politics is equated with the zealous determination to follow politically or 
ideologically motivated objectives in the teeth of evidence indicating the effectiveness 
of alternative policies.
Against these accounts, we acknowledge and accept the fundamentally political 
nature of the policy process. Policy making involves complex choices between 
competing political priorities and policy alternatives within the limits of the 
available resources. Whilst evidence of the effects of a given intervention may be 
well established, the issue at hand – the specific problem which advocates seek to 
resolve – may not be identified as a political priority by policy makers. Other policy 
ac ors may advocate that the financial resources or time in the legislative programme 
needed to address this problem instead be devoted to other issues. Even where an 
issue enters onto the policy agenda, the evidence of its effectiveness may be disputed, 
or may need to be weighed against additional evidence of its (potentially negative) 
consequences in other area. This may involve considerations of its effects beyond 
the area of health, including the wider impact on the economy and society. Within 
democratic regimes at least, debates about the use of evidence in the policy-making 
process are inextricably linked to questions of political legitimacy and democratic 
accountability. Policy makers must remain cognisant of the citizens they govern, and 
respond to the policy priorities they identify, and their decisions must be justifiable 
to those same citizens. Politics then is not a barrier to evidence use, but the defining 
character of the environment in which evidence is used. Within this overtly political 
understanding of the policy-making process, empirical evidence can inform, but 
cannot settle, the contests between competing interests, values and ideas which lie 
at the heart of that process. 
The idea that policy should be informed by evidence, but cannot be derived from 
it, raises important questions about how we should evaluate evidence use by decision 
makers. What constitutes a ‘good’ use of evidence within the policy-making process? 
How ought evidence be collected, interpreted and used by policy makers? How 
can evidence use, and the need for effective policy, be weighed against the need for 
popular legitimacy and accountability to those governed? In this article, we engage 
with these questions and offer a potential framework for guiding and evaluating 
evidence use by policy makers. We introduce the concept of ‘good governance’ of 
evidence to examine and evaluate the process of evidence use by policy makers. We 
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argue that a ‘good’ use of evidence by policy makers should be judged not in terms 
of the substantive policy decisions reached, but rather how those policy decisions 
are taken and the ways in which evidence is identified, interpreted and deployed to 
inform those decisions. The framework we propose is designed to be used both as a 
tool for policy makers seeking to use evidence effectively to inform decisions and as 
an analytical framework for policy analysts evaluating evidence use in policy making.
Evidence-based health policy
A now extensive literature exists on EBPM within the field of health policy, and 
beyond. Typically ‘evidence’ is equated with the scientific outputs of research-focused 
institutions (universities, research institutes, think tanks and non-governmental 
organisations). It is the role of scientists and intermediary actors (for example, 
knowledge brokers) to assure that those in key decision-making positions can access 
and understand relevant evidence. A range of studies focus on the factors facilitating 
and impeding the transfer of evidence from its site of production to the policy-
making environment (Lavis et al, 2008; Mitton et al, 2007b; Innvaer et al, 2002b; 
Oliver et al, 2014a).
This predominant ‘two worlds’ model seeks to increase the use of evidence by 
bridging the divide between researchers and policy makers. While there is increasing 
recognition that such a view presents an oversimplified account of complex, highly 
political policy-making processes, it has proved remarkably persistent amongst 
commentators and practitioners. Oliver and colleagues’ systematic review (2014b) note 
that this concentration on ‘getting evidence into policy’ has perpetuated a ‘theoretically 
naïve’ research agenda, focusing merely on the ‘uptake of research evidence’. In keeping 
with this, Liverani et al’s (2013) systematic review found a dearth of empirical studies 
investigating the political and institutional factors shaping evidence utilisation in the 
health sector. A recent editorial in the Journal of Epidemiology and Community Health 
highlights the limited penetration of this message amongst scholars and practitioners 
in the health community (Morgan-Trimmer, 2014).
One reason for the failure to develop more nuanced, politically-informed 
conceptualisation of evidence use may be the epistemological challenge such an 
account poses to advocates of EBPM who come from a clinical or epidemiological 
background, in which they are trained to consider ‘evidence’ as fixed and absolute. 
Within these disciplines methodologically rigorous research identifies ‘truths’ about the 
world, on which rational policies should be based. Despite authors from Carol Weiss 
(1979)  to Nutley and colleagues (2007) noting the variety of meanings attributed to 
‘evidence use’ or ‘research utilisation,’ much of the discourse around evidence for policy 
making continues to frame the issue in terms of the ‘barriers’ preventing evidence use. 
This implies that evidence use is a single, decontextualised and uncontested event, in 
which a clear body of existing evidence can be used as the basis for policy, without 
engaging with the political realities of the policy-making process.
Evaluating the evidence base
Debates around the production of policy-relevant evidence have often focused on 
the ‘hierarchy of evidence’, which identifies randomised controlled trials (RCTs) as 
the supposed ‘gold standard’ of evidence (cf Padian et al, 2010; Paxton et al, 2005). 
D
el
iv
er
ed
 b
y 
In
ge
nt
a 
to
: L
on
do
n 
Sc
ho
ol
 o
f H
yg
ie
ne
 &
 T
ro
pi
ca
l M
ed
ici
ne
IP
 : 
19
4.
80
.2
29
.2
44
 O
n:
 T
hu
, 0
6 
Ap
r 2
01
7 
12
:3
7:
56
Co
py
rig
ht
  T
he
 P
ol
icy
 P
re
ss
Benjamin Hawkins and Justin Parkhurst
578
Adherence to this conception of evidence is particularly strong in the field of health 
policy, given the close relationship to evidence-based medicine. An emerging literature, 
however, questions the appropriateness of such evidential hierarchies when addressing 
complex social issues (Worrall, 2010; La Caze and Colyvan, undated; Greenhalgh and 
Russell, 2006). Petticrew and Roberts (2003) remind us that hierarchies of evidence 
were specifically developed to evaluate evidence of intervention effects – which is 
only one of the things about which decision makers might be concerned, and may 
not be easily translated to evaluate certain kinds of issues or policy programmes.
Whilst this approach may be appropriate to clinical intervention trials in evidence-
based medicine, policy making in its entirety cannot be reduced to debates about 
‘what works’, or what can be shown to work within the methodological confines of 
the randomised controlled trial (RCT) (or of meta-analyses of multiple RCTs). At 
times policy makers will wish to understand the effectiveness of different intervention 
options, but ultimately policy-making is an ‘authoritative allocation of values’ (Easton, 
1971) which attempts to pursue the right course of action in a given context, at 
a particular time, for a certain group of people and with a particular allocation of 
resources (Greenhalgh and Russell, 2006, 35). It is about taking and implementing 
political decisions, which are informed, but not dictated, by relevant bodies of research 
evidence. While this is apparent to policy makers and many social scientists studying 
these processes, within much of the health community there remains a dominant and 
powerful discourse calling for more evidence of ‘what works’ to guide policy making. 
The risk in this approach is that it further obscures the importance of competing 
values and interests in policy debates, serving to depoliticise the policy-making process 
in the name of methodological best practice.  
The suggestion that there are technical solutions to what are inherently political 
problems is reminiscent of Stone’s (1997) observation that policy debates are often 
debates about values masquerading as debates about facts. In other words, policy 
debates may be framed in terms of the presence or absence of evidence for a policy, 
or as being between evidence-based and non-evidence-based solutions to a problem. 
Yet each alternative may be supported by valid, relevant evidence. For example, in 
the UK, health advocates have campaigned consistently for a minimum unit price 
(MUP) for alcohol (Hawkins and Holden, 2013; Holden and Hawkins, 2012), citing 
evidence of the health benefits resulting from reductions in consumption (Babor 
et al, 2010). In contrast, opponents challenged the evidence base, citing alternative 
studies of the negative impacts of the policy (McCambridge et al, 2013). The UK 
government rejected a MUP citing an apparent lack of evidence (Browne, 2013); a 
decision which was criticised by public health advocates as a failure to implement 
an evidence-based policy measure (Gornall, 2014).
Within the framework presented here, these criticisms misapprehend the nature 
of the decision faced by the government. They assume that improving public health 
is a shared objective within the political community when, in reality, governments 
must weigh the health benefits achieved through alcohol pricing against a range of 
other political concerns (for example, the economic importance of the alcohol industry, 
and public acceptability of interventions in the lifestyle choices of consumers). The 
rhetorical importance of ‘evidence’ as a legitimating factor for both policy advocates 
and decision makers is clear. However, the justification of decisions in terms of the 
presence or absence of evidence obscures the fundamentally political nature of the 
policy decisions.  
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Knowledge translation and uptake 
In her seminal work, Carol Weiss (1979) presented six models of research dissemination 
and impact on policy: the knowledge driven, problem solving, interactive, political, tactical 
and enlightenment models. In the knowledge driven and problem solving models, 
research may spur on policy debates or be used consciously and intentionally by policy 
makers to reach ‘evidence-based’ decisions to social problems. The interactive model 
highlights the interactions between researchers and policy makers in identifying and 
developing solutions to policy issues. At the other end of the scale, the political and 
tactical models describe the strategic use of evidence to pursue policy objectives (for 
example, highlighting research findings which support a favoured policy approach) or 
to deflect criticism that an issue is being ignored (for example, conducting research on 
an issue as a means of demonstrating its importance whilst delaying substantive policy 
measures). Under Weiss’ enlightenment model, however, it is noted that the impact 
of research may be more indirect, resulting from the wider diffusion of knowledge 
through society (see also Innvaer et al, 2002a; Ottoson, 2009; and Jones et al, 2009, 
for more recent discussions).
Despite recognising the multiple – often diffuse and indirect – ways in which 
research findings and evidence may be distributed through society and may impact 
on policy, much of the study of knowledge translation, and the rhetoric of policy 
actors, remains implicitly grounded with a rationalist framework, focusing on direct, 
transactional forms of policy influence. Smith (2013a) synthesises findings from 
five independent reviews of knowledge translation literature (Contandriopoulos 
et al, 2010; Innvaer et al, 2002a; Mitton et al, 2007a; Nutley et al, 2007; Walter 
et al, 2005), noting that the most popular recommendations to increase the use 
of research in policy and practice were to: ensure research is accessible; develop 
ongoing, collaborative relationships between researchers and policy makers; improve 
structural communication channels; and ensure there are sufficiently high incentives 
for researchers to engage in knowledge exchange. The assumption behind this is that 
if enough evidence arrives in the hands of key decision makers in the correct form 
it will resolve policy dilemmas and lead to more effective outcomes. Yet this would 
only be feasible where there is no contestation over the goals or desired outcomes 
of a policy.
Scholars in the field of interpretative policy studies have highlighted that evidence is 
unable to resolve policy controversies which revolve around contested and competing 
value systems or issue frames (Russell et al, 2008; Schön and Rein, 1994). A number of 
empirical examples of health issues illustrate these points. Vamos and colleagues (2008) 
found that the arguments for or against Human Papiloma Virus (HPV) vaccination 
revolved more around ‘moral, religious, political, economic, and sociocultural 
arguments’ (2008, 302) than analyses of evidence. Similarly, Parkhurst’s (2012) 
investigation of HIV prevention policy illustrates how selection and interpretation 
of epidemiological evidence to support or oppose the US’s President’s Emergency 
Plan for AIDS Relief  (PEPFAR) programme could be traced to differences in deep 
core beliefs about sexual morality. Others have explored the moral dimension of 
debates over harm reduction programmes for drug users (Keane, 2003; Rhodes et al, 
2010). Lavis et al (2002), draw on literature from political science to identify ideas, 
interests, and institutions as key factors influencing the use of health services research 
in policy making (see also Lavis et al, 2003).  Similarly, Smith (2013a) utilises both 
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ideational and institutional theories to explain the use of evidence in recent UK 
health policy decisions.
Evidence-informed policy making
The studies cited above have led to a re-evaluation of the terms in which the current 
debate on evidence use in policy making is couched. The language of evidence-based 
policy – implying that there is a coherent, self-evident and uncontested body of 
research evidence which can (and should) be translated into policy measures – has 
given way to evidence-informed policy (see Oxman et al, 2009). This implies a shift 
towards a process-based, rather than outcome-based understanding of evidence use. 
This language implies that policy should be made in light of relevant evidence on 
the issues at stake – but permits recognition of the political nature of the decision-
making process in which there are competing political priorities, often with their own 
evidence bases (see Barnes and Parkhurst, 2014). Policy makers will take account of a 
range of other political factors (for example, stakeholder interests, available resources 
or institutional constraints), whilst being informed by relevant bodies of evidence. 
The shift towards a discourse of evidence-informed policy making (EIPM) in the 
health field has made only slow progress. For example, the term ‘evidence-informed 
policy’ returns only 56 results published between 2011 and 2014 in the PubMed 
database, whilst ‘evidence-based policy’ yields 211 results over the same period. Just 
as the health field is slowly adopting more nuanced language, however, other fields 
of public policy are being urged to emulate its use of hierarchies of evidence to 
guide decision making. The UK government has recently established a set of ‘what 
works’ centres, for instance, which attempt to apply the health sector approach to 
intervention effectiveness evaluations to policies in areas such as crime, education, and 
the management of an aging population (UK Government, 2013). Similarly, in the 
United States, the Coalition for Evidence-Based Policy uses examples from the health 
policy and medical domains to advocate for greater use of evidence of ‘what works’ 
in social policy (Coalition for Evidence-Based Policy, 2015). Such efforts represent 
attempts to establish allegedly ‘depoliticised’ governance structures or processes by 
removing all but technical considerations of intervention effect from decision-making 
criteria. In contrast, the concept of EIPM emphasises the popular-democratic, rather 
than technocratic basis of legitimacy, in the policy-making process. 
The recent contributions to the literature challenging depoliticised accounts of 
evidence use represent important attempts to move beyond the still-predominant 
EBPM model. This article aims to build on, and supplement, these insights in two 
ways; firstly by making explicit the political nature of the policy-making process and 
the consequences of this for our understanding of the role of evidence in policy 
making; and secondly, by developing a framework for analysing evidence use through 
engagement with the concept of ‘governance.’ As discussed above, political contestation 
provides the central pillar on which new understandings of evidence use in policy 
must lie. Yet there remains an important normative goal to ensure evidence is used 
effectively and appropriately. In the following section, we propose an analytical 
framework to guide and evaluate evidence use by policy makers. 
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The ‘good governance’ of evidence in policy-making
Whilst it is impossible to derive policy prescriptions exclusively from research evidence, 
it is nonetheless important that decision makers take into account relevant bodies 
of evidence (for example, on the effects and effectiveness of proposed interventions) 
when making policy decisions. This raises questions about what the relevant bodies 
of evidence for that decision might be, how this is decided, and what constitutes an 
adequate consideration and effective use of that evidence. Framing these questions 
around the use of evidence as a governance issue allows further reflection on what 
constitutes the ‘good governance’ of evidence in policy-making.  
There is no single definition of good governance, although the concept is widely 
deployed and debated, particularly within the field of international development. 
Various United Nations (UN) agencies use the term in differing and overlapping 
ways. For example, the UN Economic and Social Commission for Asia and the Pacific 
(2009) states that good governance has eight major characteristics: ‘It is participatory, 
consensus oriented, accountable, transparent, responsive, effective and efficient, 
equitable and inclusive and follows the rule of law’. The UN Economic Commission 
for Africa alternatively defines good governance as implying ‘participation, transparent, 
accountable, effective and equitable management of the public affairs’ (2013, 7). Other 
definitions abound, with Grindle (2007), for instance, providing a comparison of a 
set of international development actors’ definitions of the concept. Given the focus 
on both efficiency and accountability present within many of these frameworks, 
Rhodes has argued that the concept of good governance ‘marries the new public 
management to the advocacy of liberal democracy’ (Rhodes, 2000, 57). In other 
words, it underlines the need for governments to produce not just effective responses 
to issues of importance to those they govern, but to put in place mechanisms through 
which those affected by specific policies can feed into the decision-making process 
and through which policy makers can be called to account for their actions.
Within the variety of definitions available, there appear to be two fundamental 
categories of criteria used to judge the governance of a policy environment: those 
which focus on the outcomes it produces (for example, efficiency, effectiveness); and 
those which comment on the processes by which decisions are made and implemented 
(for example, accountability, transparency). The first category, which emerges from 
the field of public administration, defines good governance in terms of the ability to 
achieve predetermined objectives (Grindle, 2007; Woods, 1999); the second focuses 
on decision making and implementation, equating good governance with processes 
that facilitate citizen participation and/or reflect their views, are transparent, and 
abide by the rule of law (Grindle, 2007; Woods, 1999). 
Discourses of EBPM typically take an outcome-based approach to evidence use, 
equating ‘good’ evidence use with the adoption of a specific policy indicated by a 
particular body of evidence. In contrast to this, we offer a process-based account 
of evidence use in decision making, which merges concerns about the quality and 
appropriateness of the evidence informing policy decisions with an analysis of how 
evidence is deployed by policy makers, derived from theories of good governance. 
Principles of good scholarly practice exist within all disciplines, and are of central 
importance in evaluating the quality of research evidence, and thus the credence 
which should be afforded to it in policy making. Decision makers must evaluate the 
strength of the evidence they handle. This includes awareness by evidence users of 
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the source of a given piece of evidence, including potential conflicts of interest by 
its producers which may affect its credibility (for example, think tanks with links to 
specific industries). Similarly, the established standards of systematic, rigorous, and 
internally valid review of evidence should guide the practices of evidence users, for 
example the evidence advisory bodies tasked with informing policy (cf National 
Health and Medical Research Council [Australia], 1999; Higgins and Green, 2011; 
Hagen-Zanker and Mallett, 2013). There is a need also to ensure that all appropriate, 
relevant bodies of evidence are identified and considered for each policy issue. This 
requires decision makers to consider evidence about multiple aspects of the policy 
debate, including those pertaining to potential externalities arising from a policy 
decision, as well as the core objectives of the policy. For example, whilst there may be 
evidence that increases in the price of alcohol or tobacco may yield population-level 
health benefits through reduced consumption, there may be other evidence about 
the wider social or economic consequences of the policy which must be considered 
alongside that supporting the principal health objectives of the policy.
In identifying the relevant evidence, policy makers must also set aside 
decontextualised claims about the strength of different forms of evidence generated 
by particular methodologies. These may bias decision makers towards certain types of 
study which may not be the most relevant or useful for understanding and evaluating 
certain policy issues and their proposed solutions (Mulgan, 2005). Recent debates 
about the over-reliance on RCTs, noted above are a case in point (Pearce and Raman, 
2014). Although systematic reviews of experimental trials may be the most appropriate 
form of evidence to evaluate certain types of intervention effect, they do not capture 
ot er relevant concerns of policy makers such as the social desirability of a policy, 
the human rights implications, and equity considerations (Petticrew and Roberts, 
2003). Examples of such policy issues range from the moral messages associated 
with drug policies, to the rights implications of quarantine or mandatory disclosure 
policies, to social attitudes to health problems brought about by ‘lifestyle’ factors (for 
example, smoking and alcohol consumption). In light of the multiple considerations 
policy makers deal with when evaluating evidence, Cookson (2005) has argued for 
the optimisation rather than maximisation of evidence use. We follow this assertion, 
arguing for the need to judge the relevance of a piece of evidence according to its 
appropriateness to address a specific policy problem, rather than assuming relevance is 
measured by a single methodological hierarchy.
Whilst policy decisions should be informed by relevant bodies of sound evidence, 
they must also be representative of the policy preferences expressed by citizens, and 
policy makers must be accountable to those governed for their decisions. The policies 
they adopt, the evidence they marshal to support their decisions and the interpretation 
of that evidence should be transparent, and thus open to contestation by policy actors 
and citizens. These three concepts are closely related, speak to, and have been widely 
discussed by scholars in the field of Science and Technology Studies (STS) concerned 
with the links between knowledge utilisation and democratic processes (cf Rayner, 
2003; Ezrahi, 1990; Jasanoff, 2011).
As decisions over which bodies of evidence to use, and when and how to use them, 
embed particular values and political priorities, good governance principles require 
policy makers to be explicit about how evidence is deployed in the decision-making 
process (Pearce and Raman, 2014). Policy makers must be explicit also about the wider 
political, economic and practical considerations which influence decisions alongside 
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evidence. This avoids attempts to ‘depoliticise’ the policy processes in the name of 
technocratic forms of decision making. Instead, policy makers should acknowledge 
the competing interests and political priorities at stake in any policy decision. The 
categories we identify to evaluate the good governance of evidence in policy-making 
– appropriateness, accountability, transparency and contestability –  are explained further 
in Table 1, with examples of how these concepts might be operationalised in both 
policy making and analysis. 
Proposing a framework for evaluating the good governance of evidence use 
necessarily requires a decision to privilege certain criteria over others. The choices of 
category made here reflect the specific context in which we are working, as well as our 
disciplinary backgrounds and research foci. As such, the good governance criteria put 
forward will be open to contestation; indeed they are designed explicitly to provoke 
reflection and debate on practices of evidence use and the criteria for their evaluation. 
However, the analytical categories proposed, we argue, allow sufficient flexibility 
for them to be applicable in a range of different political and cultural settings. The 
categories we identify for evaluating the good governance of evidence exist at both 
what Heidegger (1962) terms the ontological and the ontic level (see also Howarth, 
2000). At the ontological levels, they point to the need to evaluate evidence use in 
terms of a specific set of criteria associated with the appropriateness of the evidence 
used, the process through which it is deployed, and the accountability of policy makers 
to those affected by the decisions taken. The specific, ‘ontic’ content, we suggest, 
must be appropriate to the circumstances and settings in which policy debates, or 
the attempts to evaluate them, occur. This will vary across space and time, and the 
ontological categories identified will be filled out with different propositional content 
in different contexts. These categories must therefore be applied to the specific cases 
in a way that is thus analogous to Wittgenstein’s (1953) account of ‘applying a rule’. 
In other words, each will need to be explicated and defined in the specific contexts 
in which they are deployed. For example, the ways in which accountability is defined, 
or social concerns addressed, must be tailored to local contexts and decision-making 
structures.
In defining and applying good governance criteria, we must take account of the 
political context and the policy issue in question. This requires reflexivity both on 
the part of practitioners in using evidence, and scholars in evaluating these practices. 
Making explicit the relevant considerations in a policy decision can serve as an 
important first step in identifying which bodies of evidence are relevant to the 
decision at hand. Proposing analytical categories based on principles of appropriateness, 
accountability, transparency and contestability to those governed, we argue, allows sufficient 
flexibility for them to be applicable in a range of settings.
Institutionalising the good governance of evidence
As highlighted above, the limitations of the EBPM have been acknowledged by 
some scholars, yet progress towards more nuanced understandings of evidence use 
in policy making has been limited. The concept of the good governance of evidence 
attempts to accelerate this process by reiterating the political nature of policy making 
and providing an analytical framework for the evaluation of evidence use by decision 
makers within this context. It combines the desire of the health sciences for evidentiary 
validity with the recognition of the contested nature of the policy-making process 
D
el
iv
er
ed
 b
y 
In
ge
nt
a 
to
: L
on
do
n 
Sc
ho
ol
 o
f H
yg
ie
ne
 &
 T
ro
pi
ca
l M
ed
ici
ne
IP
 : 
19
4.
80
.2
29
.2
44
 O
n:
 T
hu
, 0
6 
Ap
r 2
01
7 
12
:3
7:
56
Co
py
rig
ht
  T
he
 P
ol
icy
 P
re
ss
Table 1: Key criteria of the good governance of evidence
Concept Definition and explanation Examples
Appropriateness The selection of evidence 
determined by the policy 
issue at hand and the 
requirements of the decision 
to be taken. Different 
types of evidence will be 
appropriate for different 
issues and types of decision. 
Evaluation of evidence 
selection requires an explicit 
statement of decision 
criteria by policy makers. 
Judgements about the 
quality of evidence to 
be based on established 
methodologic principles 
pertaining to the type 
of research undertaken 
(for example, qualitative 
interviews versus clinical 
trials) and data generated.
The approach is analogous to the methods of Multi-
Criteria Decision Analysis (Croskerry et al, 2013), which 
typically require an initial statement of all relevant decision 
criteria and an attempt to weigh, or prioritise, different 
considerations in the policy decision.  
Application of evidence quality criteria, appropriate to 
the type of research being considered. For example, if 
intervention effect is a concern, hierarches such as those 
provided by the GRADE criteria or others may be most 
relevant (Guyatt et al, 2008). Alternatively, concerns over 
cost implications may require the use of economic models 
with their own quality criteria. Similarly, political concerns 
over public acceptability may instead require evidence 
provided from surveys judged by their own criteria of rigour 
(for example, appropriate sample size and representation).
 
In combination this involves taking steps to ensure that 
one has the right criteria for evaluating the evidence used, 
as well as the right evidence for the particular policy 
problem being addressed.
Accountability Accountability systems 
would differ between 
evidence advisory bodies 
(EABs) and evidence users. 
In both cases, however, 
there should be clear 
links back to the public 
to ensure principles of 
democratic accountability 
are maintained. As 
highlighted above, the 
need for accountability 
must be balanced against 
the need for independence 
in evaluating the quality 
and appropriateness of 
evidence.
A wide range of managerial and oversight arrangements 
are possible. 
 
For EABs, rules and structures must be established 
to connect them to public representatives, whilst 
maintaining their professional autonomy. Formal 
constitutions, with specific procedures in place for their 
amendment, are one way this may be achieved (cf the 
NICE Charter (NICE, 2013)in the UK which explicitly 
addresses many of these issues).
 
Constitutions for EABs are mandated by political actors, 
and thus indirectly by the citizens they represent. 
They define roles and responsibilities and thus ensure 
that these bodies can pursue their objectives within 
the parameters of their constitution without fear of 
punishment or retribution. 
 
At the same time they create oversight mechanisms 
to ensure EABs fulfil their tasks adequately and do not 
overstep their mandate. In extremis, constitutions may 
be amended to reflect emerging needs or shifting public 
priorities, but with a higher threshold for change than 
simple laws. 
Other decision makers who utilise evidence (ministers, 
civil servants, government agencies), should also 
be accountable to the public to ensure that those 
decisions promote public interests. There will be 
differences in how direct the accountability may be 
– for example, heads of agencies may be appointed 
by government ministers and held to account by 
legislative procedures in differing ways. In the case of 
government agencies the constitutional approach may 
also apply.
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Transparency Decisions over which 
evidence to review and 
use to inform policy are of 
great political significance. 
How the relevant evidence 
base for a given policy 
decision was identified 
and deployed, and which 
social, political and 
economic considerations 
were prioritised in arriving 
at these decisions must, 
therefore, be clearly 
visible and open to public 
scrutiny.
Examples through which transparency can be achieved 
include: 
Public access to decisions or minutes of meetings; 
Scrutiny by academics, NGOs and the media; 
Freedom of information rules.
Contestability Deriving from the basic 
scientific principles of 
making ideas subject 
to open questioning 
through publication 
and peer review, 
mechanisms must be 
established to challenge 
the evidence used to 
inform a policy decision, 
that is, to question the 
appropriateness of the 
evidence used as defined 
above.
Appeals procedures over the decisions of regulatory 
agencies; 
Public consultations and stakeholder events at different 
stages of the policy-making process; 
Public debate and advocacy.
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and the need for transparency and accountability. However, in order to operationalise 
the good governance of evidence, there is a need to put in place structures which 
embed the good governance principles outlined above. 
Policy decisions, and the use of evidence within policy making, occur within 
institutional settings and broader normative and cultural frameworks. Once formal 
institutions are established they can be hard to change, due to the bureaucratic inertia 
of staff and the path dependency of structures in place (Wilsford, 1994). Informal 
processes and norms can become similarly entrenched in decision-making processes 
if their operation leads to widespread social and bureaucratic acceptance (Peters, 
2005). As such, principles relating to the good governance of evidence may also be 
institutionalised in both formal and informal decision-making structures. 
Whilst much of the knowledge translation literature discussed above focuses on the 
role of key individuals in the policy process and the importance of personal relationships 
between scientists and policy makers, these relationships are often unsustainable in the 
long term. Even assuming the ability of well-placed individuals to ensure evidence 
use at certain times and in certain policy domains, the constant movement of officials 
between policy domains and roles leads to a lack of institutional memory regarding 
evidence use and requires a constantly evolving process of relationship building (cf 
Smith, 2013b; Flitcroft et al, 2011; Hunsmann, 2012 ). Similarly, the reliance on key 
individuals means that evidence use will vary greatly between health issues (as well 
as across policy domains) depending on the dispositions of key policy makers in 
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each area, and the ability of scholars and knowledge brokers to gain access to them. 
Knowledge brokers may offer only one form of evidence to policy makers or present 
only evidence which support a particular course of action. Health researchers, for 
example, are likely to frame issues around the health impacts of a measure, and may 
set aside externalities or wider consequences of the policy (and thus the evidence 
of these). It is thus an ad hoc rather than a scalable model of evidence use. There is 
therefore a need to develop institutional structures that establish and maintain good 
governance practices in evidence use, independent of the particular individuals 
within the policy process who may advocate the use of particular pieces of evidence. 
Attempts to improve processes of evidence use in decision making which eschew this 
institutional component risk undermining both their effectiveness and sustainability. 
The work of groups like EVIPNet has focused on supporting agencies (or 
‘platforms’) rather than merely training individuals (cf Cheung et al, 2011; Lavis and 
Panisset, 2010). These are important steps which could further be developed with the 
more explicit governance focus outlined here. Processes of institutionalisation must 
look to establish not only the rules dictating good practices of evidence review; they 
must also address governance structures and bureaucratic linkages to determine how 
they serve to inform political decision makers who should remain accountable to 
local populations. Current conceptualisations of evidence-based, and even evidence-
informed, policy demonstrate only limited engagement with these issues. 
The specific form of the institutional structures put in place will be context specific. 
Different political systems and cultures will emphasise accountability, contestability, 
autonomy, independence, and transparency in different ways. Transparency, for 
example, can be established in a range of ways, including freedom of information 
(FOI) legislation, publication of meeting proceedings, and media scrutiny, all of 
which differ greatly between polities. For example, FOI laws at the EU level are 
m re extensive than in many member states, yet the minutes of Council meetings are 
not published. Accountability to the public may also be achieved through different, 
locally determined means. For example, in the UK the National Health Service has 
introduced citizens’ juries, and the National Institute of Health and Care Excellence 
(NICE) has undertaken public consultations on social values (Abelson et al, 2013); 
while in Brazil efforts were made to institutionalise the ‘right to health’ through the 
1988 Citizens Constitution and subsequent efforts to build local health councils to 
increase participation of marginalised populations (Coelho, 2013; see Abelson et al 
(2013) for a review and mapping of examples of deliberative strategies across the 
health sector). Legislation and rules can also be directly developed to govern the 
use of evidence in decision making, as seen in Mexico’s case of legally mandating 
evaluations of key social interventions (Castro et al, 2009), or the WHO’s development 
of formal guidelines for health policy guideline development (WHO, 2003). In each 
example, the measures implemented reflect the realities of the governance situation 
at the specific place and time. Despite the specific institutional arrangements which 
emerge, the core principles remain that evidence is an important part of the decision-
making process, that no single body of evidence can dictate a policy decision, and 
that evidence bodies do not replace decision makers in their roles as the legitimate 
representatives of their citizenry. 
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Conclusions and implications
This paper builds on the now extensive literature on knowledge translation and 
evidence use in the policy-making process. We eschew the narrow, reductionist 
conceptions of evidence-based policy making, which continue to dominate the 
field of health policy and risk taking root in social policy discourse more broadly. 
Our aim is to bring together the important concerns at the core EBPM movement 
with a more nuanced conception of evidence-informed policy making. Our starting 
point is an explicit recognition that policy making is an inherently political process 
which involves competing calls for the attention of policy makers, and for the finite 
resources that they have at their disposal. Policy decisions involve complex political 
choices which reflect competing norms, values and interests, and may involve relevant 
bodies of evidence at each stage. As such, a process-oriented account of the governance 
of evidence, rather than an outcome-oriented approach, is required to judge what 
constitutes a ‘good’ evidence use in policy making. 
The fundamentally political nature of policy making is often missed by calls for 
evidence-based policy, which neglect the fact that there are multiple, and often 
competing, bodies of potentially relevant evidence to which policy makers have 
recourse in identifying policy priorities and taking decisions. Policy advocates pursuing 
different political agendas couch their arguments in terms of evidence-based policy, 
highlighting the forms of evidence which support their particular issue framing and the 
course of action they advocate. What are often presented as arguments about evidence 
are often actually contests between competing agendas and political priorities. Scholars 
have noted that the existence of competing policy frames (Schön and Rein, 1994) 
makes appeals to evidence alone ineffective in resolving policy controversies. The 
rejection of a particular policy or intervention, despite evidence of its effectiveness, 
may not be because that evidence has been ignored, but because other policy issues 
or outcomes have been prioritised. This distinction is important, but often missed, 
in the current thinking on EBPM. The decision not to adopt the measure does not 
invalidate the evidence of the measure’s effectiveness, nor the gravity of the problem, 
but underlines that policy decisions, made in the light of multiple bodies of relevant 
evidence, are the consequence of a complex range of political factors. 
The appeal to scientific evidence is a powerful and persuasive rationale for policy 
decisions, reflecting wider moves towards technocratic forms of decision making 
(Lewis, 2003). It is a justification for both government action and inaction on policy 
problems. Laying bare the fundamentally political nature of the policy-making 
process removes the ability of decision makers to abdicate responsibility for their 
decisions. Instead, it forces them to explain and justify their actions to those affected 
by them, thus reinforcing transparency and accountability in the policy process. It is 
important to recast the term politics to shed it of the negative connotations it has in 
discourses of EBPM. Understood in this way, politics is not the barrier to evidence 
use, but the defining condition of the policy-making process in which evidence use 
occurs. Far from undermining the drive for good policy which underlies the EBPM 
movement, embracing the political nature of this process is the key to facilitating 
effective evidence use by policy makers and institutionalising mechanisms to ensure 
effective evidence use.
The concept of good governance employed in this article provides a conceptual 
framework for evaluating evidence use in policy making. The good governance 
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approach to evidence use recognises the importance of maintaining democratic 
principles within processes of evidence utilisation, including issues of accountability, 
transparency and contestability, while acknowledging the need for standards of good 
evidentiary practice in the identification, interpretation and use of evidence. The good 
governance principles must be institutionalised and specific structures put in place 
to embed these principles. We recognise that the meaning which these categories 
have for the relevant policy actors will vary across policy issues, time and space. As 
such, they need to be applied to the specific context and recast in terms of the local 
meanings they obtain in different settings. We aim here to foster debate around what 
constitutes the good governance of evidence, with a conceptualisation that combines 
principles of scientific best practice with those of democratic representation. This, it 
is hoped, will lead to further analytical insight or refinement amongst scholars and 
more effective decision making by policy actors.
Acknowledgements
This work has developed as part of the Getting Research into Policy in Health (GRIP-
Health) project, supported by a grant from the European Research Council (Project 
ID#282118).
References
Abelson, J, Blacksher, EA, Li, KK, Boesveld, SE, Goold, SD, 2013, Public deliberation 
in health policy and bioethics: Mapping an emerging, interdisciplinary field, Public 
Deliberation 9, 5
Babor, TF, Caetano, R, Casswell, S, Edwards, G, Giesbrecht, N, Graham, K, Grube, 
JW, Hill, L, Holder, H, Homel, R, Livingston, M, Osterberg, E, Rehm, J, Room, R, 
Rossow, I, 2010, Alcohol: No ordinary commodity: Research and public policy, Oxford: 
Oxford University Press
Barnes, A, Parkhurst, JO, 2014, Can global health policy be depoliticised? A critique 
of global calls for evidence-based policy, in Yamey, G, Brown, G (eds), Handbook of 
global health policy, Hoboken, NJ: Wiley-Blackwell
Browne, J, 2013, Government’s response to the alcohol strategy consultation, www.
gov.uk/government/speeches/governments-response-to-the-alcohol-strategy-
consultation 
Castro, M F, Lopez-Acevedo, G, Busjeet, GB, Ordonez, XF, 2009, Mexico’s M&E 
system: Scaling up from the sectoral to the national level, Washington, DC: World Bank
Cheung, A, Lavis, J, Hamandi, A, El-Jardali, F, Sachs, J, Sewankambo, N, Knowledge-
Translation Platform Evaluation Team, 2011, Climate for evidence-informed health 
systems: A print media analysis in 44 low- and middle-income countries that host 
knowledge-translation platforms, Health Research Policy and Systems 9, 7
Coalition For Evidence-Based Policy, 2015, Our Mission, http://coalition4evidence.
org
Coelho, VSP, 2013, What did we learn about citizen involvement in the health policy 
process: Lessons from Brazil, Public Deliberation 9, 9
Contandriopoulos, D, Lemire, M, Denis, J-L, Tremblay, É, 2010, Knowledge exchange 
processes in organizations and policy arenas: A narrative systematic review of the 
literature, Milbank Quarterly 88, 444–83
Cookson, R, 2005, Evidence-based policy making in health care: What it is and what 
it isn’t, Health Services Research & Policy 10, 118–21
D
el
iv
er
ed
 b
y 
In
ge
nt
a 
to
: L
on
do
n 
Sc
ho
ol
 o
f H
yg
ie
ne
 &
 T
ro
pi
ca
l M
ed
ici
ne
IP
 : 
19
4.
80
.2
29
.2
44
 O
n:
 T
hu
, 0
6 
Ap
r 2
01
7 
12
:3
7:
56
Co
py
rig
ht
  T
he
 P
ol
icy
 P
re
ss
The ‘good governance’ of evidence in health policy
589
Croskerry, P, Singhal, G, Mamede, S, 2013, Cognitive debiasing 1: Origins of bias and 
theory of debiasing, BMJ Quality & Safety 22, ii58-ii64 
Easton, D, 1971, The political system: An inquiry into the state of political science, New 
York: Alfred A Knopf
Ezrahi, Y, 1990, The descent of Icarus: Science and the transformation of contemporary democracy, 
Cambridge, MA: Harvard University Press
Feldman, PH, Nadash, P, Gursen, M, 2001, Improving communication between 
researchers and policy makers in long-term care: Or, researchers are from Mars; 
policy makers are from Venus, Gerontologist 41, 312–21
Flitcroft, K, Gillespie, J, Salkeld, G, Carter, S, Trevena, L, 2011, Getting evidence into 
policy: The need for deliberative strategies?, Social Science & Medicine 72, 1039–46
Garner, P, Kale, R, Dickson, R, Dans, T, Salinas, R, 1998, Getting research findings into 
practice: Implementing research findings in developing countries, BMJ 317, 531–5
Gornall, J, 2014, Under the influence, BMJ 348, f7646
Greenhalgh, T, Russell, J, 2006 Reframing evidence synthesis as rhetorical action in 
the policy making drama, Healthcare policy = Politiques de santé, 1, 34–42
Greenhalgh, T, Wieringa, S, 2011, Is it time to drop the ‘knowledge translation’ 
metaphor? A critical literature review, Royal Society of Medicine 104, 501–09
Grindle, MS, 2007, Good enough governance revisited, Development Policy Review 
25, 533–74
Guyatt, GH, Oxman, AD, Vist, GE, Kunz, R, Falck-Ytter, Y, Alonso-Coello, P, 
Schünemann, HJ, 2008, GRADE: An emerging consensus on rating quality of 
evidence and strength of recommendations, BMJ 336, 924–6
Hagen-Zanker, J, Mallett, R, 2013, How to do a rigorous, evidence-focused literature review 
in international development: A guidance note, London: Overseas Development Institute
Hawkins, B, Holden, C, 2013, Framing the alcohol policy debate: Industry actors and 
the regulation of the UK beverage alcohol market, Critical Policy Studies 7, 1, 53–71 
Heidegger, M, 1962, Being and time, Oxford: Basil Blackwell 
Higgins, JP, Green, S, 2011, Cochrane handbook for systematic reviews of interventions, 
version 5.1.0, Cochrane Collaboration
Holden, C, Hawkins, B, 2012, ‘Whisky gloss’: The alcohol industry, devolution and 
policy communities in Scotland, Public Policy and Administration 28, 3, 253–273
Howarth, D, 2000, Discourse concepts in the social sciences, Buckingham: Open University 
Press
Hunsmann, M, 2012, Limits to evidence-based health policymaking: Policy hurdles to 
structural HIV prevention in Tanzania, Social Science & Medicine 74, 10,1477–1485
Innvaer, S, Vist, G, Trommald, M, Oxman, A, 2002a, Health policy-makers’ perceptions 
of their use of evidence: A systematic review, Health Services Research & Policy 7, 
239–44
Jasanoff, S, 2011, Constitutional moments in governing science and technology, Science 
& Engineering Ethics 17, 621–38
Jones, N, Datta, A, Jones, H, 2009, Knowledge, policy and power: Six dimensions of the 
knowledge-development policy interface, London: Overseas Development Institute
Keane, H, 2003, Critiques of harm reduction, morality and the promise of human 
rights, International Journal of Drug Policy 14, 227–32
La Caze, A, Colyvan, M, (unpublished), Evidence-based policy: Promises and 
challenges, www.colyvan.com/papers/ebp.pdf
D
el
iv
er
ed
 b
y 
In
ge
nt
a 
to
: L
on
do
n 
Sc
ho
ol
 o
f H
yg
ie
ne
 &
 T
ro
pi
ca
l M
ed
ici
ne
IP
 : 
19
4.
80
.2
29
.2
44
 O
n:
 T
hu
, 0
6 
Ap
r 2
01
7 
12
:3
7:
56
Co
py
rig
ht
  T
he
 P
ol
icy
 P
re
ss
Benjamin Hawkins and Justin Parkhurst
590
Lavis, JN, Oxman, AD, Moynihan, R, Paulsen, EJ, 2008, Evidence-informed health 
policy 1: Synthesis of findings from a multi-method study of organizations that 
support the use of research evidence, Implementation Science 3, 53
Lavis, JN, Panisset, U, 2010, EVIPNet: Africa’s first series of policy briefs to support 
evidence-informed policymaking, International Journal of Technology Assessment in 
Health Care 26, 229–32
Lavis, JN, Robertson, D, Woodside, JM, Mcleod, CB, Abelson, J, 2003, How can 
research organizations more effectively transfer research knowledge to decision 
makers? Milbank Quarterly 81, 2, 221–48
Lavis, JN, Ross, SE, Hurley, JE, Hohenadel, JM, Stoddart, GL, Woodward, CA, Abelson, 
J, 2002, Examining the role of health services research in public policymaking, 
Milbank Quarterly 80, 125–54
Lee, JW, 2003, Science and the health of the poor, Bulletin of the World Health 
Organisation 81, 473
Lewis, JM, 2003, Evidence-based policy: A technocratic wish in a political world, in 
Lin, V, Gibson, B (eds), Evidence-based health policy: Problems and possibilities, Oxford: 
Oxford University Press
Liverani, M, Hawkins, B, Parkhurst, JO, 2013, Political and institutional influences on 
the use of evidence in public health policy: A systematic review, PloS One 8, e77404
McCambridge, J, Hawkins, B, Holden, C, 2013, Industry use of evidence to influence 
alcohol policy: A case study of submissions to the 2008 Scottish government 
onsultation, PLoS Medicine 10, 4 
Mitton, C, Adair, CE, Mckenzie, E, Patten, SB, Perry, BW, 2007a, Knowledge transfer 
and exchange: Review and synthesis of the literature, Milbank Quarterly 85, 729–68
Morgan-Trimmer, S, 2014, Policy is political; our ideas about knowledge translation 
must be too, Epidemiology and Community Health 68, 1010–1011
Mulgan, G, 2005, Government, knowledge and the business of policy making: The 
potential and limits of evidence-based policy, Evidence & Policy 1, 215–26
National Health And Medical Research Council [Australia], 1999, How to review 
the evidence: Systematic identification and review of the scientific literature, Canberra: 
Commonwealth of Australia
NICE (National Institute for Health and Care Excellence), 2013, NICE Charter, www.
nice.org.uk/Media/Default/About/Who-we-are/NICE_Charter.pdf
Nutley, SM, Walter, I, Davies, HTO, 2007, Using evidence: How research can inform public 
services, Bristol: Policy Press
Oliver, K, Innvaer, S, Lorenc, T, Woodman, J, Thomas, J, 2014a, A systematic review 
of barriers to and facilitators of the use of evidence by policymakers, BMC Health 
Services Research 14, 2
Oliver, K, Lorenc, T & Innvaer, S, 2014b, New directions in evidence-based policy 
research: A critical analysis of the literature, Health Research Policy and Systems 12, 34
Ottoson, JM, 2009, Knowledge-for-action theories in evaluation: Knowledge 
utilization, diffusion, implementation, transfer, and translation, New Directions for 
Evaluation 124, 7–20
Oxman, AD, Lavis, JN, Lewin, S, Fretheim, A, 2009, SUPPORT Tools for evidence-
informed health policymaking (STP) 1: What is evidence-informed policymaking?, 
Health Research Policy and Systems 7, S1
Padian, NS, Mccoy, SI, Balkus, JE, Wasserheit, JN, 2010, Weighing the gold in the gold 
standard: Challenges in HIV prevention research, AIDS 24, 621–35
D
el
iv
er
ed
 b
y 
In
ge
nt
a 
to
: L
on
do
n 
Sc
ho
ol
 o
f H
yg
ie
ne
 &
 T
ro
pi
ca
l M
ed
ici
ne
IP
 : 
19
4.
80
.2
29
.2
44
 O
n:
 T
hu
, 0
6 
Ap
r 2
01
7 
12
:3
7:
56
Co
py
rig
ht
  T
he
 P
ol
icy
 P
re
ss
The ‘good governance’ of evidence in health policy
591
Parkhurst, JO, 2012, Framing, ideology and evidence: Uganda’s HIV success and the 
development of PEPFAR’s ‘ABC’ policy for HIV prevention, Evidence & Policy 8, 
19–38
Pawson, R, 2006, Evidence-based policy: A realist perspective, London: Sage
Paxton, A, Maine, D, Freedman, L, Lobis, S, 2005, The evidence for emergency obstetric 
care, International Journal of Gynecology and Obstetrics 88, 181–93
Pearce, W, Raman, S, 2014, The new randomised controlled trials (RCT) movement 
in public policy: Challenges of epistemic governance, Policy Sciences 47, 387–402
Peters, G, 2005, Institutional theory in political science, London: Continuum
Petticrew, M, Roberts, H, 2003, Evidence, hierarchies, and typologies: Horses for 
courses, Epidemiology and Community Health 57, 527–9
Rayner, S 2003, Democracy in the age of assessment: Reflections on the roles of 
expertise and democracy in public-sector decision making, Science and Public Policy 
30, 163–70
Rhodes, RA, 2000, Governance and public administration, in Pierre, J (ed), Debating 
governance: Authority steering and democracy, Oxford: Oxford University Press
Rhodes, T, Sarang, A, Vickerman, P, Hickman, M, 2010, Policy resistance to harm 
reduction for drug users and potential effect of change, BMJ 341
Russell, J, Greenhalgh, T, Byrne, E, McDonnell, J, 2008, Recognizing rhetoric in 
health care policy analysis, Health Services Research & Policy 13, 40–46
Sanderson, I, 2009, Intelligent policy making for a complex world: Pragmatism, 
evidence and learning, Political Studies 57, 699–719
Schön, DA, Rein, M, 1994, Frame reflection: Toward the resolution of intractable policy 
controversies, New York: Basic Books
Shaxson, L, Bielak, A, Ahmed, I, Brien, D, Conant, B, Middleton, A, Fisher, C, Gwyn, 
E, Klerkx, L, 2012, Expanding our understanding of K (KT, KE, KTT, KMb, KB, KM, 
etc), Hamilton, Ontario: United Nations University, Institute for Water, Environment 
and Health
Smith, K, 2013a, Beyond evidence based policy in public health: The interplay of ideas, 
London: Palgrave Macmillan
Smith, K, 2013b, Institutional filters: The translation and re-circulation of ideas about 
health inequalities within policy, Policy & Politics 41, 81–100
Stone, DA, 1997, Policy paradox: The art of political decision making, New York: WW 
Norton 
SUPPORT programme, undated, Executive summary, Oslo: Nasjonalt kunnskapssenter 
for helsetjenesten, www.kunnskapssenteret.no/en/publications/support-tools-for-
evidence-informed-health-policymaking-stp?vis=sammendrag
Thamlikitkul, V, 2006, Bridging the gap between knowledge and action for health: 
Case studies, Bulletin of the World Health Organization 84, 603–07
UK Government, 2013, What Works: Evidence centres for social policy, London: UK 
Cabinet Office
United Nations Economic and Social Commission for Asia and the Pacific, 2009, 
What is good governance?, www.unescap.org/pdd/prs/ProjectActivities/Ongoing/
gg/governance.asp 
United Nations Economic Commission for Africa, Governance and Public 
Administration Division (GPAD), 2013, The role of parliament in promoting good 
governance, Addis Ababa: United Nations ECA
D
el
iv
er
ed
 b
y 
In
ge
nt
a 
to
: L
on
do
n 
Sc
ho
ol
 o
f H
yg
ie
ne
 &
 T
ro
pi
ca
l M
ed
ici
ne
IP
 : 
19
4.
80
.2
29
.2
44
 O
n:
 T
hu
, 0
6 
Ap
r 2
01
7 
12
:3
7:
56
Co
py
rig
ht
  T
he
 P
ol
icy
 P
re
ss
Benjamin Hawkins and Justin Parkhurst
592
Vamos, CA, Mcdermott, RJ, Daley, EM, 2008, The HPV vaccine: Framing the 
arguments FOR and AGAINST mandatory vaccination of all middle school girls, 
School Health 78, 302–09
Walter, I, Nutley, S, Davies, H, 2005, What works to promote evidence-based practice? 
A cross-sector review, Evidence & Policy 1, 335–64
Weiss, CH, 1979, The many meanings of research utilization, Public Administration 
Review 39, 426–31
WHO (World Health Organization), 2003, WHO guidelines, Geneva: WHO
Wilsford, D, 1994, Path dependency, or why history makes it difficult but not impossible 
to reform health care systems in a big way, Public Policy 14, 251–83
Wittgenstein, L 1953, Philosophical investigations, Oxford: Basil Blackwood
Woods, N, 1999, Good governance in international organizations, Global Governance 
5, 39–61
Worrall, J, 2010, Evidence: Philosophy of science meets medicine, Evaluation in Clinical 
Practice 16, 356–62
